h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UNIBSi008-C
Registration Summary
:
A
P
E
C
AT-MC-C12
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UNIBSi008-C
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UNIBSi008-C (RRID:CVCL_YB53)
Alternative name(s)
AT-MC-C12
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
8th July 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University of Brescia (UNIBS)
External Databases
Cellosaurus
CVCL_YB53
Wikidata
Q98134292
General Information
Publications
Masneri S et al. Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene. Stem cell research. 2019 Dec;41:101596.
Casamassa A et al. A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15. International journal of molecular sciences. 2020 Mar 9;21(5).
Genova E et al. Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients. Clinical pharmacology and therapeutics. 2020 Aug;108(2):358-367.
Genova E et al. Induced pluripotent stem cells to model adverse drug reactions in pediatric patients. Pharmacogenomics. 2020 Sep;21(14):975-978.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.